Sandrine Malochet-Guinamand

Sandrine Malochet-Guinamand

Auto-generated profile, based on publicly available information

Sandrine Malochet-Guinamand

Department of Rheumatology, Hôpital Gabriel Montpied, Clermont-Ferrand, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Joint Bone Spine
Verified
Journal Article
Closed access
SMSandrine Malochet-Guinamand
Sandrine Malochet-Guinamand
FDFranck Durif
Franck Durif
TTThierry Thomas
Thierry Thomas

Verified
Journal Article
Open access
PDF file
SMSylvain Mathieu
Sylvain Mathieu
MCMarion Couderc
Marion Couderc
Bruno PereiraBruno Pereira
Bruno Pereira
JDJean-Jacques Dubost
Jean-Jacques Dubost
SMSandrine Malochet-Guinamand
Sandrine Malochet-Guinamand
XMXavier Moisset
Xavier Moisset
To investigate the physiopathology of pain in chronic inflammatory rheumatic diseases (CIRDs), we assessed the prevalence of migraine and neuropathic pain in 499 patients with CIRDs. We studied 238 patients with rheumatoid arthritis, 188 with spondyloarthritis (SpA), 72 with psoriatic arthritis (PsA), and 1 unclassified. Migraine was diagnosed according to IHS migraine diagnostic criteria. Neuropathic pain was diagnosed when patients scored at least 3 on the DN4 questionnaire. Participants completed a validated self-assessment questionnaire. Migraine prevalence was 34% (165/484), and it was highest in PsA. Risk factors for migraine were a high level of anxiety, female sex, young age, and TNF-alpha inhibitor treatment (OR = 1.90 (1.13–3.25)). Besides, high disease activity was a risk factor in SpA. Blood CRP level was not significantly associated with migraine. Of 493 patients with CIRDs, 21.5% had chronic pain with neuropathic characteristics. Compared to the French general population, these patients had significantly higher prevalences of migraine (two-fold) and neuropathic pain (three-fold). This study showed that migraine and neuropathic pain frequently occurred in patients with rheumatic diseases. Therefore, upon reporting residual pain, these patients should be checked for the presence of migraine or neuropathic pain, despite adequate clinical control of rheumatic disease.

13 December 2013 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
SMSylvain Mathieu
Sylvain Mathieu
MCMarion Couderc
Marion Couderc
BGBaptiste Glace
Baptiste Glace
ATAnne Tournadre
Anne Tournadre
SMSandrine Malochet-Guinamand
Sandrine Malochet-Guinamand
MSMartin Soubrier
Martin Soubrier
The script concordance test (SCT) is a method for assessing clinical reasoning of medical students by placing them in a context of uncertainty such as they will encounter in their future daily practice. Script concordance testing is going to be included as part of the computer-based national ranking examination (iNRE).

22 August 2017 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
SMSandrine Malochet-Guinamand
Sandrine Malochet-Guinamand
Bruno PereiraBruno Pereira
Bruno Pereira
ZTZuzana Tatar
Zuzana Tatar
ATAnne Tournadre
Anne Tournadre
AMAnna Moltó
Anna Moltó
MSMartin Soubrier
Martin Soubrier
Investigate the prevalence and risk factors of low bone mineral density (BMD) in patients with axial spondyloarthritis as well as investigating the prevalence of vertebral fractures. Patients underwent BMD measurements with dual-energy X-ray absorptiometry (DXA) in the anterior-posterior lumbar spine, lateral spine and hip. We screened for vertebral fractures using vertebral fracture assessment, and then checked for syndesmophytes on the VFA images. Sociodemographic and clinical variables were collected. A total of 89 patients (41,6% female) took part in the study with a mean age of 44 ± 14 years and disease duration 10.2 ± 10.6 years. According to World Health Organization (WHO) criteria, 48,3% of patients displayed osteopenia and 6,7% osteoporosis. In the subgroup of women who underwent measurement at all sites including the lateral spine, the prevalence of osteopenia was 39.3% in the anterior-posterior spine, 32.1% in the lateral spine, and 64.3% with all sites together. VFA led to the diagnosis of at least one vertebral fracture in 6.2% of patients. On VFA, syndesmophytes were found in 24.3% of patients. The variables associated in multivariate analyses with low BMD in different measurement sites were low body mass index (BMI), a high physician’s global assessment score, a high Bath Ankylosing Spondylitis Functional Index (BASFI) score and female gender. Our study found a high prevalence (around 50%) of low BMD in SpA. Conversely, the prevalence of osteoporosis (6.7% according to WHO criteria) and vertebral fractures (6.2%) was lower than generally reported in the literature. While lateral spine BMD measurement did little to improve the detection of osteopenia in women, the sample size was not large enough to enable us to draw definite conclusions.

29 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GVGaelle Vial
Gaelle Vial
CLCéline Lambert
Céline Lambert
Bruno PereiraBruno Pereira
Bruno Pereira
MCMarion Couderc
Marion Couderc
SMSandrine Malochet-Guinamand
Sandrine Malochet-Guinamand
ATAnne Tournadre
Anne Tournadre
Rheumatoid arthritis (RA) is associated with a decrease in lean mass and stability or even an increase in fat and ectopic adipose tissue. A few data are available on body composition changes under treatment, and data are still controversial. Body composition was assessed before initiation of biologic disease-modifying antirheumatic drug (bDMARD) and after 6 and 12 months of stable treatment. Eighty-three RA patients were included (75% of women, mean age 58.5 ± 10.8 years) of whom 47 patients treated with TNF inhibitor (TNFi), 18 with non-TNF-targeted biologic (Non-TNFi), and 18 with conventional DMARD (cDMARD) alone. In the TNFi group, total lean mass, fat-free mass index, and skeletal muscle mass index significantly increased at 1 year. An increase in subcutaneous adipose tissue (SAT) without change for the visceral or body fat composition was associated. These changes were associated with an improvement in strength and walking test. In non-TNFi or cDMARD groups, no significant changes for body composition or muscle function were observed at 1 year. However, no significant differences for treatment x time interaction were noted between group treatments. In active RA patients starting first bDMARD, treatment with TNFi over 1 year was associated with favorable changes of the body composition and muscle function.

23 July 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
MVMarie Viprey
Marie Viprey
BMBlandine Merle
Blandine Merle
BRBenjamin Riche
Benjamin Riche
JFJulie Freyssenge
Julie Freyssenge
PRPascal Rippert
Pascal Rippert
ASAnne-Marie Schott
Anne-Marie Schott
The worldwide global increase in serum 25-hydroxyvitamin D (25(OH)D) measurements has led some countries to restrict reimbursement for certain clinical situations only. Another approach could consist in providing physicians with screening tools in order to better target blood test prescription. The objective of the SCOPYD study was to identify the best combination of predictors of serum VitD concentration among adults aged 18–70 years. Potential risk factors for VitD deficiency were collected using a comprehensive self-administered questionnaire. A multivariable linear regression was used to build a predictive model of serum 25(OH)D concentration. Among 2488 participants, 1080 (43.4%) had VitD deficiency (<50 nmol/L) and 195 (7.8%) had severe deficiency (<25 nmol/L). The final model included sunlight exposure in the preceding week and during the last holidays, month of blood sampling, age, sex, body mass index, skin phototype, employment, smoking, sport practice, latitude, and VitD supplementation in preceding year. The area under the curve was 0.82 (95% CI (0.78; 0.85)) for severe deficiency. The model predicted severe deficiency with a sensitivity of 77.9% (95% CI (69.1; 85.7)) and a specificity of 68.3% (95% CI (64.8; 71.9)). We identified a set of predictors of severe VitD deficiency that are easy to collect in routine that may help to better target patients for serum 25(OH)D concentration determination.